Stock Market & Financial Investment News

News Breaks January 14, 2013 07:27 EDT ARIA ARIAD price target raised to $28 from $23 at Leerink Leerink raised its price target for ARIAD citing results from its physician survey on chronic myeloid leukemia treatment. The firm keeps an Outperform rating on the stock. News For ARIA From The Last 14 Days Check below for free stories on ARIA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 07:34 EDT ARIA UBS to host a conference Subscribe for More Information May 17, 2013 08:22 EDT ARIA ARIAD shares should be bought on weakness, says BMO Capital Subscribe for More Information May 16, 2013 07:29 EDT ARIA Leerink to host a bus tour Boston Biopharma Bus Tour travels throughout Boston on May 16-17. May 7, 2013 12:02 EDT ARIA ARIAD management to meet with JMP Securities Subscribe for More Information 07:39 EDT ARIA ARIAD reports Q1 EPS (36c), consensus (38c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.